Meet Us Contact Us

News

Oxipit ChestEye Study: Comparison of Commercial AI Software Performance for Radiograph Lung Nodule Detection and Bone Age Prediction
2024 January 15th
A research paper comparing the performance of commercially available AI algorithms was published in the Radiology journal. While multiple commercial artificial intelligence (AI) products for assessing radiographs exist in the market, comparable performance data for these algorithms is limited.
Blackford Partners With Oxipit To Expand Chest X-Ray AI Solution Offering
2023 November 22nd
Blackford, the pioneering strategic radiology AI platform and solutions provider, today announced a partnership with AI medical imaging company Oxipit. The agreement will bring innovative Oxipit’s chest x-ray products to Blackford’s enterprise AI platform.
LUMC Deploys New Oxipit AI Application For CT PE Detection
2023 October 19th
Leiden University Medical Center (The Netherlands) expands cooperation with AI medical imaging company Oxipit by deploying the latest Oxipit product - AI quality assurance tool for CT Pulmonary Embolism (PE). The LUMC deployment was facilitated through the radiology imaging solution by Sectra and its integration capabilities.
How A Small Team In Vilnius Beat Silicon Valley: The Story Of The First Autonomous AI Imaging Application
2023 October 9th
Last April Oxipit took the medical imaging world by storm. The medical imaging company received a CE Class IIb certificate for the first autonomous AI imaging application ChestLink. Learn about the team who made this innovation possible.
Oxipit ChestEye Study: Evaluating AI Performance for Detecting Airspace Disease, Pneumothorax, and Pleural Effusion
2023 September 29th
A study led by Louis Lind Plesner, MD comparing the performance of four commercial AI CXR tools was published in the Radiology Journal, with Oxipit ChestEye among the ones tested. The study evaluated AI algorithm performance for detecting airspace disease, pneumothorax, and pleural effusion.
Oxipit Quality Study: Using AI to Identify Missed Findings in CXR
2023 April 13th
A study by researchers at Mahajan Imaging and CARPL.ai was conducted to evaluate the performance of diagnostic AI tools for quality assurance. The study found that nearly 1% of chest radiographs included clinically significant diagnostic mistakes, which were identified by Oxipit Quality AI software. The study was presented at the ECR2023 annual meeting earlier in March.
ChestLink Study: AI Accurately Identifies Normal and Abnormal Chest X-Rays
2023 March 20th
An AI tool can accurately identify normal and abnormal chest X-rays in a clinical setting, according to a study published in Radiology. The tool may greatly alleviate the heavy workload experienced by radiologists globally.  
Oxipit Partners With CARPL To Increase Global Reach Of AI Diagnostic Products
2023 March 2nd
At the European Congress of Radiology in Vienna Oxipit announced that its diagnostic AI solutions will be available on the CARPL platform. CARPL platform users will have access to the full Oxipit AI product portfolio: ChestLink for healthy patient report automation, Quality - for real-time quality assurance and ChestEye - for preliminary reports. The move further builds on Oxipit strategy to increase global reach of company’s products.
Oxipit Secures Brazilian ANVISA Clearance for ChestEye AI Suite
2023 February 15th
The regulatory approval paves the way for ChestEye deployments in the Brazilian market. The application is already cleared for use in Europe and Australia. The Brazilian Health Regulatory Agency’s approval is one of Oxipit steps to increase global reach for company products.
Oxipit Closes $4.9M Funding Round To Advance AI Autonomy in Medical Imaging
2023 January 19th
AI medical imaging company Oxipit closed a $4.9M funding round led by Taiwania Capital, Practica Capital, and Coinvest Capital. Angel investors also participated in this round. The funding will help Oxipit advance its development of autonomous AI medical imaging applications and support market expansion into new geographic regions, with particular focus on the United Kingdom.

Media About Us

Society for Imaging Informatics in Medicine:

Oxipit’s Chest X-ray Search Solution Selected as One of Top Innovations by SIIM

European Congress of Radiology (ECR 2018):

Oxipit’s Peer Reviewed Poster On Multiclass Chest X-Ray Pathology Classification

Intel:

Press Release on our Kaggle win

Kaggle:

Interview on how we won the Intel & MobileODT Cervical Cancer Screening Competition

Kaggle:

Interview on how we won the Nature Conservancy Fisheries Monitoring Competition

Verslo Žinios:

Laurus pasaulio dirbtinio intelekto konkursuose pelnę lietuviai kuria bendrovę

Verslo Žinios:

Oxipit.ai apie dirbtinio intelekto kūrimą Vilniuje ir Lietuvos galimybes

Lietuvos rytas:

Šešių jaunų lietuvių kūrinys sužavėjo pasaulį